Cerebral amyloid angiopathy is characterized by the abnormal buildup of amyloid-beta protein in the walls of the brain’s ...

Background Published cases of iatrogenic cerebral amyloid angiopathy (iCAA) are increasing; however, their geographic ...

An opinion piece and literature review published in The Lancet looks at the risk of amyloid beta transmission through transfused blood products. Dr Susan Kohlhaas, Executive Director of Research and ...

A novel therapy recently approved by the U.S. Food and Drug Administration for patients with Alzheimer's disease amid considerable controversy should not be prescribed by physicians off-label for ...

What has long been interpreted as permanent and irreversible vascular damage may not be exclusively so. In people with Down syndrome—one of the most robust populations for studying Alzheimer's disease ...

Diffusion-weighted imaging (DWI)-positive lesions are common after intracerebral hemorrhage (ICH) and serve as an independent ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) today announced additional positive interim results for the ongoing single ascending dose portion of the Phase 1 study ...

(Yana Iskayeva/Moment/Getty Images) Alzheimer's disease is an incredibly challenging condition to study, because of both its ...

Please provide your email address to receive an email when new articles are posted on . Cerebral amyloid angiopathy was associated with a higher risk for isolated nontraumatic subdural hemorrhage in ...

A review and opinion piece published in The Lancet and led by UCL (University College London) and UCLH researchers discusses ...

Cerebral amyloid angiopathy (CAA) denotes the deposition of amyloid-β peptides within the walls of leptomeningeal and cortical blood vessels. It frequently co-occurs with Alzheimer’s disease and other ...